Key facts
- This page summarizes Ph.D. Oliver Schacht's Form 4 filing for OPGEN INC (OPGN).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2023, 16:15.
Ph.D. Oliver Schacht - 02 Mar 2023 Form 4 Insider Report for OPGEN INC (OPGN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- OPGN
- Reported as of
- 02 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2023, 16:15:18 UTC
- Prior SEC filing
- 04 Apr 2022
- Next SEC filing
- 31 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Oliver Schacht, Ph.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ph.D. Oliver Schacht filed Form 4 for OPGEN INC (OPGN) on 06 Mar 2023.
Change
- Previous filing in this sequence was filed on 04 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OPGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,875
- Change %
- +55%
- Price
- $0.000000
- Shares after
- 5,312
- Date
- 02 Mar 2023
- Ownership
- Direct
OPGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,938
- Change %
- +36%
- Price
- $0.000000
- Shares after
- 7,250
- Date
- 03 Mar 2023
- Ownership
- Direct
OPGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 250
- Date
- 02 Mar 2023
- Ownership
- As custodian for minor son
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OPGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,938
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 1,938
- Date
- 03 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,938
- Exercise price
- Footnotes
- F1, F2
OPGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,875
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 1,875
- Date
- 02 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,875
- Exercise price
- Footnotes
- F3, F4
OPGN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- Price
- $0.000000
- Shares after
- 10,000
- Date
- 02 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Represents vesting of restricted stock units ("RSUs") granted in March 2021 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.
Footnote F2
On March 3, 2021, the Reporting Person was granted 3,875 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.
Footnote F3
Represents vesting of restricted stock units ("RSUs") granted in March 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.
Footnote F4
On March 2, 2022, the Reporting Person was granted 3,750 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.
Footnote F5
Each RSU represents a contingent right to receive one share of OpGen common stock.
Footnote F6
RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.
SEC remarks
All share numbers reported on this Form 4 reflect a 1-for-20 reverse stock split of OpGen's common stock effected on January 5, 2023.